Last news
Azentio Software recognized as a Notable Vendor in Leading Research Firm's Digital Banking Engagement Platforms Report

Azentio Software recognized as a Notable Vendor in Leading Research Firm's Digital Banking Engagement Platforms Report

...

LeoLabs expands global radar coverage with its West Australian Space Radar

LeoLabs expands global radar coverage with its West Australian Space Radar

...

Vedanta Aluminium ranks 2nd in S&P Dow Jones Sustainability Index (DJSI) 2022 rankings

Vedanta Aluminium ranks 2nd in S&P Dow Jones Sustainability Index (DJSI) 2022 rankings

...

PM-International donates €1,872,000 to charity sponsoring 5,200 children around the world

PM-International donates €1,872,000 to charity sponsoring 5,200 children around the world

...

China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq

China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq

...

Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology

Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology

...

MILKEN INSTITUTE PUBLISHES RECOMMENDATIONS FOR PHILIPPINES SOVEREIGN WEALTH FUND

MILKEN INSTITUTE PUBLISHES RECOMMENDATIONS FOR PHILIPPINES SOVEREIGN WEALTH FUND

...

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China

...

menu
menu